India to Malaysia: Ipratropium Export Trade Route
India has recorded 62 verified shipments of Ipratropium exported to Malaysia, representing a combined trade value of $474.4K USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $7.7K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 61% of total export value with 4 shipments worth $288.2K USD. On the buying side, CIPLA MALAYSIA SDN BHD is the largest importer in Malaysia with $214.6K USD in purchases. The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , BABA AGENCIES — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Malaysia Ipratropium corridor is one of India's established pharmaceutical export routes, with 62 shipments documented worth a combined $474.4K USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 61% of all export value, reflecting the consolidated nature of India's ipratropium manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $7.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with ipratropium's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 31.2%, placing it at rank #20 among India's top ipratropium export destinations globally.
On the import side, key buyers of Indian ipratropium in Malaysia include CIPLA MALAYSIA SDN BHD, CIPLA MALAYSIA SDN BHD , UNI DRUG HOUSE SDN BHD and 9 others. CIPLA MALAYSIA SDN BHD is the single largest importer with 3 shipments valued at $214.6K USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ3
- Primary modeSea freight
- Top portCHENNAI AIR CARGO ACC (INMAA4)
Market Position
- Global rank#20
- Annual growth+31.2%
- Demand growth+27.9%
- Regulatory ease75/100
Top 10 Indian Ipratropium Exporters to Malaysia
Showing top 10 of 12 Indian suppliers exporting Ipratropium to Malaysia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $72.0K per shipment | 4 | $288.2K | 60.8% |
| 2 | CIPLA LIMITED Avg $88.1K per shipment | 2 | $176.2K | 37.1% |
| 3 | BABA AGENCIES Avg $230 per shipment | 22 | $5.1K | 1.1% |
| 4 | BABA AGENCIES Avg $140 per shipment | 24 | $3.4K | 0.7% |
| 5 | PLEASANT EXPORTS Avg $379 per shipment | 2 | $758 | 0.2% |
| 6 | MS MERCURY MEDICARE Avg $611 per shipment | 1 | $611 | 0.1% |
| 7 | PARISAL PHARMACY Avg $111 per shipment | 1 | $111 | 0.0% |
| 8 | RAGHAVENDRA MEDICALS Avg $76 per shipment | 1 | $76 | 0.0% |
| 9 | OCEAN PHARMACEUTICAL Avg $24 per shipment | 1 | $24 | 0.0% |
| 10 | M/S MERCURY MEDICARE Avg $0 per shipment | 1 | $0 | 0.0% |
This table shows the top 10 of 12 Indian companies exporting ipratropium to Malaysia, ranked by total trade value. The listed exporters are: CIPLA LIMITED, CIPLA LIMITED , BABA AGENCIES, BABA AGENCIES , PLEASANT EXPORTS, MS MERCURY MEDICARE, PARISAL PHARMACY , RAGHAVENDRA MEDICALS , OCEAN PHARMACEUTICAL , M/S MERCURY MEDICARE . CIPLA LIMITED is the dominant supplier with 4 shipments worth $288.2K USD, giving it a 61% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Showing top 10 of 12 total Indian exporters on the India to Malaysia Ipratropium export route.
Top 10 Ipratropium Importers in Malaysia
Showing top 10 of 12 known buyers in Malaysia receiving Ipratropium shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ipratropium in Malaysia include CIPLA MALAYSIA SDN BHD, CIPLA MALAYSIA SDN BHD , UNI DRUG HOUSE SDN BHD, NILA JAMAL ENTERPRISE, NILA JAMAL ENTERPRISE , among 12 total buyers. The largest importer is CIPLA MALAYSIA SDN BHD, accounting for $214.6K USD across 3 shipments — representing 45% of all ipratropium imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA MALAYSIA SDN BHD | 3 | $214.6K | 45.2% |
| 2 | CIPLA MALAYSIA SDN BHD | 2 | $176.2K | 37.1% |
| 3 | UNI DRUG HOUSE SDN BHD | 1 | $73.6K | 15.5% |
| 4 | NILA JAMAL ENTERPRISE | 21 | $4.9K | 1.0% |
| 5 | NILA JAMAL ENTERPRISE | 26 | $3.5K | 0.7% |
| 6 | DLS FREIGHT SERVICES | 2 | $758 | 0.2% |
| 7 | SEQUENCE MEDICARE SDN BHD | 1 | $611 | 0.1% |
| 8 | VITAL RANK SDN BHD | 1 | $174 | 0.0% |
| 9 | GKV GLOBAL SERVICES | 1 | $24 | 0.0% |
| 10 | EFS LOGISTICS SDN BHD | 1 | $0 | 0.0% |
Showing top 10 of 12 Ipratropium importers in Malaysia on this route.
Top 10 Ipratropium Formulations Imported by Malaysia
Showing top 10 of 30 product formulations shipped on the India to Malaysia Ipratropium route, ranked by trade value
Malaysia imports a wide range of ipratropium formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DUOLIN RESPULES (IPRATROPIUM BROMIDE 0.5MG+SALBUTAMOL SULPHATE 2.5MG(PER 2.5ML) RESPULES) (INV.QTY. 12800 PA — accounts for $126.9K USD across 1 shipments. There are 30 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DUOLIN RESPULES (IPRATROPIUM BROMIDE 0.5MG+SALBUTAMOL SULPHATE 2.5MG(PER 2.5ML) RESPULES) (INV.QTY. 12800 PA | 1 | $126.9K | 26.8% |
| 2 | DUOLIN RESPULES IPRATROPIUM BROMIDE 0 5MG SALBUTAMOL SULPHATE 2 5 MG PER 2 5ML RESPULES INV QTY 10112 PACK 4X5X2 5M | 1 | $113.0K | 23.8% |
| 3 | DUOLIN RESPULES IPRATROPIUM BROMIDE 0 5MG SALBUTAMOL SULPHATE 2 5MG PER 2 5ML RESPULES 8000PACKx4X5 160000NUM 2 5ML | 1 | $87.2K | 18.4% |
| 4 | DUOLIN RESPULES (IPRATROPIUM BROMIDE 0.5MG+SALBUTAMOL SULPHATE 2.5MG(PER 2.5ML) RESPULES)(INV.QTY. 7488 PACK | 1 | $73.6K | 15.5% |
| 5 | DUOLIN RESPULES (IPRATROPIUM BROMIDE 0.5MG+SALBUTAMOL SULPHATE 2.5MG(PER 2.5ML) RESPULES) ( INV.QTY.4992 PAC | 1 | $49.3K | 10.4% |
| 6 | DUOLIN RESPULES (IPRATROPIUM BROMIDE 0.5MG+SALBUTAMOL SULPHATE 2.5MG(PER 2.5ML) RESPULES)( INV. QTY.1472 PAC | 1 | $14.4K | 3.0% |
| 7 | DUOLIN RESPULES 2.5ML (IPRATROPIUM BROMI | 19 | $2.3K | 0.5% |
| 8 | DUOLIN RESPULES 2.5MLIPRATROPIUM BROMIDE & LEVOSALBUTAMOL RESPIRATOR SOLUTION | 6 | $1.3K | 0.3% |
| 9 | DUOLIN RESPULES 2.5ML (IPRATROPIUM BROMIDE & LEVOSALBUTAMOL RESPIRATOR SOLUTION)NOS | 2 | $1.0K | 0.2% |
| 10 | DUOLIN RESPULES 2.5ML(IPRATROPIUM BROMIDE & LEVOSALBUTAMOL RESPIRATOR SOLUTION )NOS | 1 | $856 | 0.2% |
Showing top 10 of 30 Ipratropium formulations imported by Malaysia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 73%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
CHENNAI AIR CARGO ACC (INMAA4) handles the highest volume with 27 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's ipratropium exports to Malaysia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Malaysia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , BABA AGENCIES — together account for 99% of total trade value on this route. The average shipment value of $7.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as duolin respules ipratropium bromide 0 5mg salbutamol sulphate 2 5 mg per 2 5ml respules inv qty 10112 pack 4x5x2 5m and duolin respules ipratropium bromide 0 5mg salbutamol sulphate 2 5mg per 2 5ml respules 8000packx4x5 160000num 2 5ml, suggesting that buyers in Malaysia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CIPLA MALAYSIA SDN BHD is the largest importer with 3 shipments worth $214.6K USD — representing 45% of all ipratropium imports from India on this route. A total of 12 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $474.4K
- Avg. Shipment
- $7.7K
- Suppliers
- 12
- Buyers
- 12
- Transit (Sea)
- ~34 days
- Annual Growth
- +31.2%
Related Analysis
Other Ipratropium Routes
Unlock the Full India to Malaysia Ipratropium Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 62 shipments on this route.
Frequently Asked Questions — India to Malaysia Ipratropium Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ipratropium to Malaysia?
The leading Indian exporters of Ipratropium to Malaysia are CIPLA LIMITED, CIPLA LIMITED , BABA AGENCIES. CIPLA LIMITED holds the largest market share at approximately 61% of total trade value on this route.
Q What is the total value of Ipratropium exports from India to Malaysia?
India exports Ipratropium to Malaysia worth approximately $474.4K USD across 62 recorded shipments. The average value per shipment is $7.7K USD.
Q Which ports does India use to ship Ipratropium to Malaysia?
The most active port of origin is CHENNAI AIR CARGO ACC (INMAA4) with 27 shipments. Indian exporters primarily use sea freight for this route, with 73% of shipments going by sea and 21% by air.
Q How long does shipping take from India to Malaysia for Ipratropium?
The average transit time for Ipratropium shipments from India to Malaysia is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Malaysia Ipratropium trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 31.2% with demand growth tracking at 27.9%. The route is ranked #20 among India's top Ipratropium export destinations globally.
Q How many suppliers are active on the India to Malaysia Ipratropium route?
There are currently 12 active Indian suppliers exporting Ipratropium to Malaysia. The market is moderately concentrated with CIPLA LIMITED accounting for 61% of total shipment value.
Q Who are the main importers of Ipratropium from India in Malaysia?
The leading importers of Indian Ipratropium in Malaysia include CIPLA MALAYSIA SDN BHD, CIPLA MALAYSIA SDN BHD , UNI DRUG HOUSE SDN BHD, NILA JAMAL ENTERPRISE, NILA JAMAL ENTERPRISE . CIPLA MALAYSIA SDN BHD is the largest buyer with 3 shipments worth $214.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Malaysia export trade corridor identified from Indian Customs (DGFT) records for Ipratropium.
- 2.Supplier/Buyer Matching: 12 Indian exporters and 12 importers in Malaysia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 62 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
62 Verified Shipments
12 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists